Actively Recruiting
Continuous Glucose Monitoring (CGM) in an Underserved Population
Led by Tulane University · Updated on 2026-05-05
50
Participants Needed
1
Research Sites
67 weeks
Total Duration
On this page
Sponsors
T
Tulane University
Lead Sponsor
A
Abbott
Collaborating Sponsor
AI-Summary
What this Trial Is About
The investigators aim is to conduct a randomized clinical trial in an underserved population who are either uninsured or on Medicaid and taking at least one injection of insulin daily. The investigators believe that this study will lead to considerable alleviation of health disparities and provide better care for an underserved population. This will be a pilot study to evaluate the feasibility of such a trial in this population before doing a larger multicenter trial.
CONDITIONS
Official Title
Continuous Glucose Monitoring (CGM) in an Underserved Population
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18-75 years
- Diagnosis of type 2 diabetes mellitus
- HbA1c of 7.5% or higher
- Receiving at least one insulin injection daily
- Established patient at primary care, endocrinology, or diabetes clinics in New Orleans and surrounding areas
- Having Medicaid, free care, or no insurance
- Able to speak and understand English and provide informed consent
You will not qualify if you...
- Diagnosis of type 1 diabetes mellitus
- Currently using continuous glucose monitoring or an insulin pump
- Advanced kidney disease or estimated glomerular filtration rate (eGFR) less than 40
- Serious medical conditions making participation difficult as judged by the investigator
- End-stage kidney disease, on dialysis, kidney transplant, hemoglobinopathies, iron therapy, or conditions interfering with HbA1c measurement
- Pregnant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Medical Center
New Orleans, Louisiana, United States, 70112
Actively Recruiting
Research Team
N
Neha Upadhyay, BDS,MPH
CONTACT
A
Ayitevi Agbodji, MD,MPH&TM
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here